Octagon Capital Advisors LP - Significant Ownership

Signature - Title
/s/ Ting Jia - Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Octagon Capital Advisors LP.

Significant Ownership of Octagon Capital Advisors LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOSS Gossamer Bio, Inc. Common Stock, $0.0001 par value 8.6% $15.3M 19.6M Octagon Capital Advisors LP Dec 31, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value 6.1% $95.1M $12.1M 2.42M +14.5% Octagon Capital Advisors LP Sep 30, 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, $0.001 par value 5.7% $4.36M 1M 0% Octagon Capital Advisors LP Sep 30, 2025
AVBP ArriVent BioPharma, Inc. Common Stock, $0.0001 par value 4.9% $36.4M 1.97M Octagon Capital Advisors LP Sep 30, 2025
TSHA Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value 3.3% $29.7M -$4.52M 9.07M -13.2% Octagon Capital Advisors LP Sep 30, 2025

Schedules 13D/G Reported by Octagon Capital Advisors LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.